The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
Aerovate Therapeutics, Inc. | COMM | 008064107 | 78,857 | 3,758,686 | SH | SOLE | 3,758,686 | 0 | 0 | ||
Akouos, Inc. | COMM | 00973J101 | 17,590 | 1,515,074 | SH | SOLE | 1,515,074 | 0 | 0 | ||
Amarin Corp | ADR | 023111206 | 5,457 | 1,069,968 | SH | SOLE | 1,069,968 | 0 | 0 | ||
Ascendis Pharma A/S | ADR | 04351P101 | 79,667 | 499,824 | SH | SOLE | 499,824 | 0 | 0 | ||
Bolt Biotherapeutics, Inc. | COMM | 097702104 | 34,844 | 2,754,437 | SH | SOLE | 2,754,437 | 0 | 0 | ||
Checkmate Pharmaceuticals Inc | COMM | 162818108 | 14,319 | 3,606,707 | SH | SOLE | 3,606,707 | 0 | 0 | ||
Fusion Pharmaceuticals Inc | COMM | 36118A100 | 618 | 78,066 | SH | SOLE | 78,066 | 0 | 0 | ||
Galera Therapeutics, Inc. | COMM | 36338D108 | 24,978 | 3,083,712 | SH | SOLE | 3,083,712 | 0 | 0 | ||
Inozyme Pharma, Inc. | COMM | 45790W108 | 23,508 | 2,028,308 | SH | SOLE | 2,028,308 | 0 | 0 | ||
Karuna Therapeutics, Inc. | COMM | 48576A100 | 238,920 | 1,953,077 | SH | SOLE | 1,953,077 | 0 | 0 | ||
Natera Inc | COMM | 632307104 | 345,794 | 3,102,960 | SH | SOLE | 3,102,960 | 0 | 0 | ||
Nextcure, Inc | COMM | 65343E108 | 18,008 | 2,671,856 | SH | SOLE | 2,671,856 | 0 | 0 | ||
Nucana Plc | ADR | 67022C106 | 14,448 | 5,599,999 | SH | SOLE | 5,599,999 | 0 | 0 | ||
Nucana Plc | Ordinary Shares | GB00BYWYV | 6,192 | 2,400,000 | SH | SOLE | 2,400,000 | 0 | 0 | ||
ObsEva SA | COMM | H5861P103 | 14,771 | 4,749,623 | SH | SOLE | 4,749,623 | 0 | 0 | ||
PDS Biotechnology Corporation | COMM | 70465T107 | 2,125 | 142,635 | SH | SOLE | 142,635 | 0 | 0 | ||
Synlogic Inc. | COMM | 87166L100 | 1,754 | 574,972 | SH | SOLE | 574,972 | 0 | 0 | ||
Vera Therapeutics, Inc. | CL A | 92337R101 | 50,571 | 2,914,776 | SH | SOLE | 2,914,776 | 0 | 0 | ||
Y-mAbs Therapeutics, Inc. | COMM | 984241109 | 62,625 | 2,194,278 | SH | SOLE | 2,194,278 | 0 | 0 | ||
ALX Oncology Holdings Inc | COMM | 00166B105 | 7,919 | 107,220 | SH | SOLE | 107,220 | 0 | 0 | ||
Abbvie Inc | COMM | 00287Y109 | 29,405 | 272,600 | SH | SOLE | 272,600 | 0 | 0 | ||
Acceleron Pharma Inc | COMM | 00434H108 | 6,813 | 39,589 | SH | SOLE | 39,589 | 0 | 0 | ||
Agenus Inc | COMM | 00847G705 | 12,308 | 2,344,410 | SH | SOLE | 2,344,410 | 0 | 0 | ||
Align Technology Inc | COMM | 016255101 | 31,275 | 47,000 | SH | SOLE | 47,000 | 0 | 0 | ||
Aligos Therapeutics Inc | COMM | 01626L105 | 1,929 | 124,342 | SH | SOLE | 124,342 | 0 | 0 | ||
AstraZeneca PLC | ADR | 046353108 | 67,764 | 1,128,272 | SH | SOLE | 1,128,272 | 0 | 0 | ||
Biogen Inc | COMM | 09062X103 | 9,401 | 33,220 | SH | SOLE | 33,220 | 0 | 0 | ||
Blueprint Medicines Corp | COMM | 09627Y109 | 18,697 | 181,860 | SH | SOLE | 181,860 | 0 | 0 | ||
Bristol-Myers Squibb Co | CALL | 110122908 | 23,668 | 400,000 | SH | Call | SOLE | 400,000 | 0 | 0 | |
CTI BioPharma Corp | COMM | 12648L601 | 6,120 | 2,074,714 | SH | SOLE | 2,074,714 | 0 | 0 | ||
Celldex Therapeutics, Inc. | COMM | 15117B202 | 7,398 | 137,032 | SH | SOLE | 137,032 | 0 | 0 | ||
ChemoCentryx Inc | COMM | 16383L106 | 8,853 | 517,708 | SH | SOLE | 517,708 | 0 | 0 | ||
ChemoCentryx Inc | PUT | 16383L956 | 8,649 | 505,800 | SH | Put | SOLE | 505,800 | 0 | 0 | |
Cyteir Therapeutics, Inc. | COMM | 23284P103 | 4,323 | 246,321 | SH | SOLE | 246,321 | 0 | 0 | ||
Cytokinetics Inc | COMM | 23282W605 | 15,248 | 426,632 | SH | SOLE | 426,632 | 0 | 0 | ||
Dexcom Inc | COMM | 252131107 | 20,379 | 37,266 | SH | SOLE | 37,266 | 0 | 0 | ||
Exelixis Inc | COMM | 30161Q104 | 10,325 | 488,414 | SH | SOLE | 488,414 | 0 | 0 | ||
Fulcrum Therapeutics Inc | COMM | 359616109 | 1,439 | 51,006 | SH | SOLE | 51,006 | 0 | 0 | ||
Guardant Health Inc | COMM | 40131M109 | 5,000 | 40,000 | SH | SOLE | 40,000 | 0 | 0 | ||
Heron Therapeutics Inc | COMM | 427746102 | 24,600 | 2,301,179 | SH | SOLE | 2,301,179 | 0 | 0 | ||
Horizon Therapeutics Pub L | SHS | G46188101 | 17,251 | 157,487 | SH | SOLE | 157,487 | 0 | 0 | ||
Immatics N.V | COMM | N44445109 | 6,217 | 478,216 | SH | SOLE | 478,216 | 0 | 0 | ||
Insmed Inc | COMM | 457669307 | 14,737 | 535,120 | SH | SOLE | 535,120 | 0 | 0 | ||
Insulet Corp | COMM | 45784P101 | 303 | 1,066 | SH | SOLE | 1,066 | 0 | 0 | ||
Intercept Pharmaceuticals In | CALL | 45845P908 | 2,822 | 190,000 | SH | Call | SOLE | 190,000 | 0 | 0 | |
Intra-Cellular Therapies Inc | COMM | 46116X101 | 8,478 | 227,419 | SH | SOLE | 227,419 | 0 | 0 | ||
Iveric Bio Inc | COMM | 46583P102 | 5,804 | 357,400 | SH | SOLE | 357,400 | 0 | 0 | ||
Iveric Bio Inc | PUT | 46583P952 | 4,146 | 255,300 | SH | Put | SOLE | 255,300 | 0 | 0 | |
Jounce Therapeutics Inc | COMM | 481116101 | 4,735 | 637,347 | SH | SOLE | 637,347 | 0 | 0 | ||
Kadmon Holdings Inc | COMM | 48283N106 | 9,113 | 1,046,312 | SH | SOLE | 1,046,312 | 0 | 0 | ||
Kura Oncology Inc | COMM | 50127T109 | 14,143 | 755,121 | SH | SOLE | 755,121 | 0 | 0 | ||
Marinus Pharmaceuticals Inc | COMM | 56854Q200 | 1,897 | 166,711 | SH | SOLE | 166,711 | 0 | 0 | ||
Merck & Co Inc | CALL | 58933Y905 | 45,066 | 600,000 | SH | Call | SOLE | 600,000 | 0 | 0 | |
Mirati Therapeutics Inc | COMM | 60468T105 | 10,066 | 56,900 | SH | SOLE | 56,900 | 0 | 0 | ||
Novocure Ltd | CALL | G6674U908 | 3,485 | 30,000 | SH | Call | SOLE | 30,000 | 0 | 0 | |
PTC Therapeutics Inc | COMM | 69366J200 | 8,559 | 230,019 | SH | SOLE | 230,019 | 0 | 0 | ||
Protagonist Therapeutics Inc | CALL | 74366E902 | 5,316 | 300,000 | SH | Call | SOLE | 300,000 | 0 | 0 | |
Protagonist Therapeutics Inc | COMM | 74366E102 | 5,275 | 297,709 | SH | SOLE | 297,709 | 0 | 0 | ||
Reata Pharmaceuticals Inc | COMM | 75615P103 | 15,845 | 157,488 | SH | SOLE | 157,488 | 0 | 0 | ||
Regeneron Pharmaceuticals | PUT | 75886F957 | 18,155 | 30,000 | SH | Put | SOLE | 30,000 | 0 | 0 | |
Regenxbio Inc | COMM | 75901B107 | 5,349 | 127,593 | SH | SOLE | 127,593 | 0 | 0 | ||
Sarepta Therapeutics, Inc. | COMM | 803607100 | 14,545 | 157,279 | SH | SOLE | 157,279 | 0 | 0 | ||
Sierra Oncology, Inc. | COMM | 82640U404 | 4,528 | 206,564 | SH | SOLE | 206,564 | 0 | 0 | ||
Syndax Pharmaceuticals Inc | COMM | 87164F105 | 7,909 | 413,841 | SH | SOLE | 413,841 | 0 | 0 | ||
Travere Therapeutics Inc | COMM | 89422G107 | 10,604 | 437,280 | SH | SOLE | 437,280 | 0 | 0 | ||
Uniqure NV | COMM | N90064101 | 2,521 | 78,742 | SH | SOLE | 78,742 | 0 | 0 | ||
United Therapeutics Corp | COMM | 91307C102 | 40,994 | 222,094 | SH | SOLE | 222,094 | 0 | 0 | ||
United Therapeutics Corp | PUT | 91307C952 | 17,443 | 94,500 | SH | Put | SOLE | 94,500 | 0 | 0 | |
Zoetis Inc | CL A | 98978V103 | 14,755 | 76,000 | SH | SOLE | 76,000 | 0 | 0 | ||
Zymeworks Inc | COMM | 98985W102 | 11,924 | 410,619 | SH | SOLE | 410,619 | 0 | 0 |